While the pathophysiological role of NADPH oxidase in PCOS remains underexplored, existing evidence links hyperandrogenemia to NOX subunit p47phox upregulation in leukocytes [50], and NOX2 inhibition mitigates ROS overproduction in PCOS ovarian GCs [51]. The gene discussed is NCF1; the disease is polycystic ovary syndrome.